OSE Immunotherapeutics
OSE Immunotherapeutics is a Healthcare & Life Sciences startup based in France, most recent round Series B, 1 tracked investor.
About OSE Immunotherapeutics
OSE Immunotherapeutics is a company founded in 2006 headquartered in France. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
OSE Immunotherapeutics is a clinical-stage biotech company developing first-in-class therapies in immuno-oncology and immuno-inflammation. The company is leading a 36-month program named “HexARN” to develop novel RNA therapeutics and delivery methods for inflammatory disorders and autoimmune diseases.
Explore OSE Immunotherapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.